about
None-endoscopic Screening for Esophageal Squamous Cell Carcinoma- A Review.Pilot genome-wide study of tandem 3' UTRs in esophageal cancer using high-throughput sequencing.comparison of the Serum Levels of Trace Elements in Areas with High or Low Rate of Esophageal Cancer.Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.Evaluation of Barrett esophagus by multiphoton microscopy.Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.Increased level of serum prostaglandin-2 in early stage of esophageal squamous cell carcinoma.Mechanisms of obesity-induced gastrointestinal neoplasiaZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinomaGenome-wide gene expression profile analyses identify CTTN as a potential prognostic marker in esophageal cancer.The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasmsPhenotype of tumor lymphatic vessels is a prognostic factor in human tongue squamous cell carcinoma.A new clinical guideline from the Royal College of Paediatrics and Child Health with a national awareness campaign accelerates brain tumor diagnosis in UK children--"HeadSmart: Be Brain Tumour Aware"Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients.Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence.Loss of p38δ mitogen-activated protein kinase expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth.The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis.Description and predictors of hospital costs of oesophageal cancer during the first year following diagnosis in Northern Ireland.A model for predicting individuals' absolute risk of esophageal adenocarcinoma: Moving toward tailored screening and prevention.Fluorescence Imaging for Cancer Screening and Surveillance.Maximizing early detection of esophageal squamous cell carcinoma via SILAC-proteomics.DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes.From blood to breath: New horizons for esophageal cancer biomarkers.Targeting the cell cycle in esophageal adenocarcinoma: an adjunct to anticancer treatmentThe role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer.Endoscopic screening for precancerous lesions of the esophagus in a high risk area in Northern Iran.Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study.The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy
P2860
Q33597366-520424C5-D60A-45A9-9E57-F95A93F7A79FQ33608707-2D51D38A-09E5-4EEF-9D04-6D84A3355414Q33798973-DE20102B-FA6B-4E8D-9509-EDC6C9719111Q33868284-610274EA-C5DF-49F5-B21C-DF410EDBDD05Q33872723-2EC7AB08-1651-4AC2-9A59-C935FF8D44C7Q33898634-0E996A2A-7FB0-4B28-B6D7-169EDD05447BQ34466680-98319987-3794-4C37-A77F-2EFD3F0EF3E1Q35062195-67B53964-0E1F-4A17-8954-DAE687D05E5EQ35068080-C46E0CF6-480C-4AB6-A4A8-02B922F356BAQ35097632-A47AB019-C27C-4FA8-A5E3-19531D6F668BQ35167866-9D79AD40-DC82-41B8-BBE5-261DD46F699BQ35399306-2F80B5F2-5B6D-4AC6-B0AD-8D453909AC96Q36142352-0BAB1C38-4046-4EFF-AB7D-F94C4669A9D1Q36618264-B60C99C1-A7C0-4B35-99D2-91F3C6ACA1E0Q36666694-923523DA-75F9-4EEA-9D8A-1189B1CEDC0FQ37153011-26BDB156-4F21-4E42-B070-0FEC7F663635Q37178449-8A347395-421D-48B6-8DA0-09EF8346FAA1Q37508817-E7BDFD5E-DAFF-4AFB-AA91-69B7C6637842Q38078018-E3326E2A-4475-4092-90F4-DE016F52FCD5Q38921914-54A528C8-2401-47F7-AA46-5597D72E29C0Q39117047-953AE82B-6C6E-4D48-85BD-323D40C9E601Q41881319-4A136EFE-30CE-4A89-95AB-6D06A6E7ED70Q41970979-BA15213C-12FD-48B0-AFB3-F62F3EBAA220Q42353202-372239F8-C0EA-4A23-AC42-C97C9CEA89BBQ42723757-8EF18000-56C8-4F8E-826C-F992E1AFE8B5Q46117374-F11687DF-FC84-4D49-87C5-C470E4FBD82BQ47838811-49851AA6-27D7-43A5-A280-0A901C6F4FA6Q53265013-1CB2E82B-7D1F-4AAF-8939-EBDE9C95D4CEQ55434774-5A2B5564-6B3A-4C45-88FA-71972C8EA0CEQ57298074-4D0254F5-8102-47C8-823F-633C0C174874
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early diagnosis of oesophageal cancer.
@en
Early diagnosis of oesophageal cancer.
@nl
type
label
Early diagnosis of oesophageal cancer.
@en
Early diagnosis of oesophageal cancer.
@nl
prefLabel
Early diagnosis of oesophageal cancer.
@en
Early diagnosis of oesophageal cancer.
@nl
P2860
P356
P1476
Early diagnosis of oesophageal cancer
@en
P2093
R C Fitzgerald
P2860
P2888
P356
10.1038/SJ.BJC.6605126
P407
P577
2009-06-09T00:00:00Z